Chronic Lymphocytic Leukaemia (CLL)
Tracks
-
| Tuesday, April 29, 2025 |
| 8:30 AM - 10:00 AM |
| Alsh |
Details
The session will be delivered by three experienced CLL physicians. In the first session, Professor Paul Moss will give a general overview of the state of the art in a number of important areas for today's patients with CLL. In the second session, Professor Martin Dyer will give an overview of the very important role of BCL2 and its inhibition in the disease. The session will conclude with Dr Dima El-Sharkawi covering quality of life and other matters for patients with CLL.
Speaker
Prof. Paul Moss
Professor Of Haematology
University of Birmingham
CLL biology and management in 2025
8:30 AM - 8:55 AM
Prof. Martin Dyer
Professor Haemato-oncology
University of Leceister
Another chemical romance; from chlorambucil to venetoclax and beyond!
8:55 AM - 9:20 AM
Dr. Dima El-Sharkawi
Haematology Consultant
The Royal Marsden Hospital
Quality of life whilst living with CLL: impact of the disease and treatment
9:25 AM - 9:50 AMChair
Piers Patten
Clinical Senior Lecturer
King's College London
Co Chair
Renata Walewska
